Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans

Journal of Experimental Medicine

Volumn 191, Issue 7, 2000, Pages 1241-1246

  Harrington, Laurie E ^a   Galvan, Marisa ^b   Baum, Linda G ^b   Altman, John D ^a   Ahmed, Rafi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytotoxic T lymphocytes; Effector T cells; Memory T cells; O glycosylation; Viral immunity

Indexed keywords

GLYCAN DERIVATIVE; LYMPHOCYTE SURFACE MARKER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE ANTIGEN;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GLYCATION; IMMUNOPHENOTYPING; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ANIMALS; CELL MEMBRANE; EPITOPES, T-LYMPHOCYTE; IMMUNOLOGIC MEMORY; KINETICS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; POLYSACCHARIDES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 0034599742     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.7.1241     Document Type: Article

References (21)

1. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science. 272:54-60.
2. + memory T cells in virus-infected hosts. J. Exp. Med. 183:1367-1375.
3. + T cells. J. Exp. Med. 186:1407-1418.
4. Murali-Krishna, K., J.D. Altman, M. Suresh, D.J. Sourdive, A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:177-187.
5. Buchmeier, M.J., and A.J. Zajac. 1999. Lymphocytic chorio-meningitis virus. In Persistent Viral Infections. R. Ahmed and I.S.Y. Chen, editors. John Wiley & Sons, Chichester, UK. 575-605.
6. + T cells from naive cells. J. Immunol. 161:641-648.
7. Jones, A.T., B. Federsppiel, L.G. Ellies, M.J. Williams, R. Burgener, V. Duronio, C.A. Smith, F. Takei, and H.J. Ziltener. 1994. Characterization of the activation-associated isoform of CD43 on murine T lymphocytes. J. Immunol. 153: 3426-3439.
8. Carlow, D.A., B. Ardman, and H.J. Ziltener. 1999. A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation. J. Immunol. 163:1441-1448.
9. Razvi, E.S., and R.M. Welsh. 1993. Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J. Virol. 67:5754-5765.
10. Sourdive, D.J., K. Murali-Krishna, J.D. Altman, A.J. Zajac, J.K. Whitmire, C. Pannetier, P. Kourilsky, B. Evavold, A. Sette, and R. Ahmed. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71-82.
11. Lin, M.Y., and R.M. Welsh. 1998. Stability and diversity of T cell receptor repertoire usage during lymphocytic chorio-meningitis virus infection of mice. J. Exp. Med. 188:1993-2005.
12. Busch, D.H., and E.G. Pamer. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:701-710.
13. Savage, P.A., J.J. Boniface, and M.M. Davis. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity. 10:485-192.
14. Barran, P., W. Fellinger, C.E. Warren, J.W. Dennis, and H.J. Ziltener. 1997. Modification of CD43 and other lymphocyte O-glycoproteins by core 2 N-acetylglucosaminyltransferase. Glycobiology. 7:129-136.
15. Piller, F., V. Piller, R.I. Fox, and M. Fukuda. 1988. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J. Biol. Chem. 263:15146-15150.
16. Mukasa, R., T. Homma, T. Ohtsuki, O. Hosono, A. Souta, T. Kitamura, M. Fukuda, S. Watanabe, and C. Morimoto. 1999. Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells. Int. Immunol. 11:259-268.
17. He, Y.W., and M.J. Bevan. 1999. High level expression of CD43 inhibits T cell receptor/CD3-mediated apoptosis. J. Exp. Med. 190:1903-1908.
18. Ellies, L.G., S. Tsuboi, B. Petryniak, J.B. Lowe, M. Fukuda, and J.D. Marth. 1998. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity. 9:881-890.
19. Tsuboi, S., and M. Fukuda. 1997. Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses. EMBO (Eur. Mol. Biol. Organ.) J. 16:6364-6373.
20. Baum, L.G., M. Pang, N.L. Perillo, T. Wu, A. Delegeane, C.H. Uittenbogaart, M. Fukuda, and J.J. Seilhamer. 1995. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J. Exp. Med. 181:877-887.
21. Blaser, C., M. Kaufmann, C. Muller, C. Zimmermann, V. Wells, L. Mallucci, and H. Pircher. 1998. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. J. Immunol. 28:2311-2319.